Skip to main content
SpringerLink
Log in

Less frequent post-thrombotic syndrome after successful catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Post-thrombotic syndrome (PTS) occurs in 20–50% of patients with proximal deep vein thrombosis (DVT). In this study, we aimed to identify potential markers of thrombolysis success at the early stage and to clarify the relationship between early thrombolysis success and subsequent PTS development in patients with acute DVT in the iliac vein. Fifty-two consecutive patients with acute iliofemoral DVT who were treated with catheter-directed thrombolysis (CDT) within 21 days of onset were enrolled. An infusion catheter with multiple side holes was placed to cover the thrombosed vessel entirely. Urokinase solution was administered either continuously or with the pulse-spray method at a dose of 480,000–720,000 IU/day over the course of 2–7 days. During CDT, unfractionated heparin (UFH) was infused simultaneously via the access sheath to prevent thrombus formation. Early success was defined as lysis grade ≥ 50% and restoration of forward flow. PTS was diagnosed based on the Villalta scale. Based on the lysis grading method, complete lysis (grade III) was achieved in 8 of 52 (16%) limbs. Lysis grade II (50–99%) was achieved in 35 of 52 (67%) limbs. Lysis grade I (< 50%) was achieved in 9 of 52 (17%) limbs. Therefore, grade II and grade III lytic outcomes (early success) were observed in 43 patients (83%). One-year clinical follow-up was performed for 43 patients (83%). PTS occurred in seven (16%) patients. Early success was more frequently observed in patients without PTS than in those with PTS (92% vs. 43%; P < 0.01). Early success was only significantly associated with PTS in the multivariate analysis. Patients with acute symptomatic iliofemoral DVT who had early success from CDT treatment during the acute phase less frequently progressed to PTS. Patients with early success tended to undergo the pulse-spray method and had a shorter interval from symptom onset to CDT. The use of pulse-spray method and early initiation of CDT since DVT onset were potential markers of thrombolysis success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kahn SR. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Progr. 2010;2010:216–20.

    Article  Google Scholar 

  2. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130:1636–61.

    Article  Google Scholar 

  3. Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol. 2006;134:357–65.

    Article  Google Scholar 

  4. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S–94S.

    Article  CAS  Google Scholar 

  5. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA Jr, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405–18.

    Article  CAS  Google Scholar 

  6. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49.

    Article  CAS  Google Scholar 

  7. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752–60.

    Article  CAS  Google Scholar 

  8. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24:209–14.

    Article  CAS  Google Scholar 

  9. Schulman S. Getting intimate with the venous thrombus. J Thromb Haemost. 2009;7:1266–7.

    Article  CAS  Google Scholar 

  10. Enden T, Haig Y, Kløw NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–8.

    Article  Google Scholar 

  11. Haig Y, Enden T, Grøtta O, Slagsvold CE, Sandvik L, Ghanima W, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3:e64–71.

    Article  Google Scholar 

  12. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240–52.

    Article  Google Scholar 

  13. Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695–702.

    Article  Google Scholar 

  14. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, et al. Catheter-directed thrombolysis vs anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost. 2009;7:1268–75.

    Article  CAS  Google Scholar 

  15. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Definition of post thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879–83.

    Article  CAS  Google Scholar 

  16. Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P, et al. Assessment of validity and reproducibility of a clinical scale for the post thrombotic syndrome. Haemostasis. 1994;24:158.

    Google Scholar 

  17. Broholm R, Sillesen H, Damsgaard MT, Jørgensen M, Just S, Jensen LP, et al. Postthrombotic syndrome and quality of life in patients with iliofemoral venous thrombosis treated with catheter-directed thrombolysis. J Vasc Surg. 2011;54:18S–25S.

    Article  Google Scholar 

  18. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE. Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis. J Vasc Interv Radiol. 2013;24:17–24.

    Article  Google Scholar 

  19. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–52.

    Article  Google Scholar 

  20. Foegh P, Jensen LP, Klitfod L, Broholm R, Bækgaard N. Editor’s choice—factors associated with long-term outcome in 191 patients with ilio-femoral DVT treated with catheter-directed thrombolysis. Eur J Vasc Endovasc Surg. 2017;53:419–24.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We want to thank Editage (http://www.editage.com) for English language editing.

Author information

Authors and Affiliations

  1. Department of Cardiology, Kakogawa Central City Hospital, 439, Kakogawacho Honmachi, Kakogawa, 675-8611, Japan

    Hiroaki Nakamura & Makoto Kadotani

  2. Department of Cardiology, Ohta Memorial Hospital, Ota, Japan

    Hitoshi Anzai

Authors
  1. Hiroaki Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hitoshi Anzai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Kadotani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Nakamura.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Human rights statements and ethical standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institution and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent was obtained from all patients who were included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, H., Anzai, H. & Kadotani, M. Less frequent post-thrombotic syndrome after successful catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Cardiovasc Interv and Ther 36, 237–245 (2021). https://doi.org/10.1007/s12928-020-00661-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-020-00661-7

Keywords

Search

Navigation